Aardvark Therapeutics names David Zhang to board
Aardvark Therapeutics (AARD) appointed clinical development leader David Zhang, Ph.D., MBA, to its Board of Directors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.